FANCB expression based on
|
KIRC : Kidney renal clear cell carcinoma *
Please note that the TPM values for gene considered is extremely low (TPM < 1).
Comparison | Statistical significance |
Normal-vs-Primary | 3.216000E-02 |
|
KIRC : Kidney renal clear cell carcinoma *
Please note that the TPM values for gene considered is extremely low (TPM < 1).
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
1.743450E-01 |
Normal-vs-Stage2 |
2.685200E-01 |
Normal-vs-Stage3 |
8.175600E-02 |
Normal-vs-Stage4 |
1.354020E-02 |
Stage1-vs-Stage2 |
8.659200E-01 |
Stage1-vs-Stage3 |
4.184800E-01 |
Stage1-vs-Stage4 |
4.316100E-02 |
Stage2-vs-Stage3 |
7.201000E-01 |
Stage2-vs-Stage4 |
7.865700E-02 |
Stage3-vs-Stage4 |
9.468300E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma *
Please note that the TPM values for gene considered is extremely low (TPM < 1).
Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
2.015700E-02 |
Normal-vs-AfricanAmerican |
9.815200E-01 |
Normal-vs-Asian |
1.613840E-01 |
Caucasian-vs-AfricanAmerican |
4.364100E-03 |
Caucasian-vs-Asian |
6.464400E-01 |
AfricanAmerican-vs-Asian |
2.166600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma *
Please note that the TPM values for gene considered is extremely low (TPM < 1).
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
2.662300E-02 |
Normal-vs-Female |
8.790200E-02 |
Male-vs-Female |
3.656400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma *
Please note that the TPM values for gene considered is extremely low (TPM < 1).
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
1.053380E-01 |
Normal-vs-Age(41-60Yrs) |
3.146100E-02 |
Normal-vs-Age(61-80Yrs) |
7.850300E-02 |
Normal-vs-Age(81-100Yrs) |
8.587400E-01 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.341400E-01 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.583200E-01 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.362400E-01 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.725400E-01 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.690400E-02 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.604420E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma *
Please note that the TPM values for gene considered is extremely low (TPM < 1).
Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
Subtype descriptions |
Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Grade 1 |
3.673000E-01 |
Normal-vs-Grade 2 |
1.075850E-01 |
Normal-vs-Grade 3 |
1.877050E-01 |
Normal-vs-Grade 4 |
8.963700E-03 |
Grade 1-vs-Grade 2 |
6.962400E-01 |
Grade 1-vs-Grade 3 |
9.351800E-01 |
Grade 1-vs-Grade 4 |
3.224000E-02 |
Grade 2-vs-Grade 3 |
6.305200E-01 |
Grade 2-vs-Grade 4 |
3.674100E-02 |
Grade 3-vs-Grade 4 |
2.617600E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma *
Please note that the TPM values for gene considered is extremely low (TPM < 1).
NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-ccA subtype |
1.393390E-01 |
Normal-vs-ccB subtype |
1.116270E-02 |
ccA subtype-vs-ccB subtype |
6.171700E-02 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma *
Please note that the TPM values for gene considered is extremely low (TPM < 1).
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
4.154200E-02 |
Normal-vs-N1 |
4.795800E-02 |
N0-vs-N1 |
1.140600E-01 |
|
|